Quipt Home Medical Corp. Transaction Investigation: Ademi Firm Examines Fairness for Public Shareholders

The Ademi Firm is investigating Quipt Home Medical Corp. (Nasdaq: QIPT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Kingswood and Forager. The transaction, valued at approximately $260 million, includes Quipt insiders receiving substantial benefits. The firm is examining whether Quipt's board of directors is fulfilling their fiduciary duties to all shareholders. Shareholders can contact the Ademi Firm for more information at gademi@ademilaw.com or toll-free: 866-264-3995.